Abbott (ABT) Tops Q2 EPS by 1c, Updates FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Abbott Labs (ABT) PT Raised to $56 at Deutsche Bank Following 2Q
July 21, 2017 8:37 AM EDTDeutsche Bank raised its price target on Abbott Labs (NYSE: ABT) to $56.00 (from $49.00) while maintaining a Buy rating following 2Q earnings report.... More
Abbott Labs (ABT) PT Raised to $57 at Barclays on 2Q Beat & FY17 EPS Raise; '2H Outlook Appears Bright'
July 21, 2017 8:32 AM EDTBarclays raised its price target on Abbott Labs (NYSE: ABT) to $57.00 (from $52.00) while maintaining a Overweight rating, following the company's second quarter earnings announcement.
Analyst Matthew Taylor notes the company delivered second quarter earnings per share and revenue results above the Street's... More
Abbott Labs (ABT) PT Raised to $62 at Argus on 2Q Beat & FY17 Raise; 'Positive View of Growth Prospects'
July 21, 2017 7:45 AM EDTArgus raised its price target on Abbott Labs (NYSE: ABT) to $62.00 (from $55.00) while maintaining a Buy rating, following the company's second quarter earnings announcement.
Analyst David Toung notes the company delivered second quarter earnings per share above consensus projections driven by positive... More
